Literature DB >> 9534706

Recurrent follicular carcinoma-oxyphilic cell type (Hürthle cell carcinoma) of the thyroid, imaging with iodine-131 and technetium-99m tetrofosmin before and after radiotherapy.

J B Bomanji1, S Gacinovic, M N Gaze, D C Costa, P J Ell.   

Abstract

A 68-year-old male with recurrence of malignant follicular carcinoma-oxyphilic cell type of the thyroid after surgery underwent whole body scintigraphy with 131I-sodium iodide and 99Tcm-tetrofosmin (Myoview). 131I scanning demonstrated local uptake most likely to be in the normal remnant, but 99Tcm-Myoview images delineated recurrence of the carcinoma in the neck, with more extensive involvement. We believe that a combination of 131I and 99Tcm-tetrofosmin imaging may be useful to assess the extent of disease in patients with recurrent Hürthle cell type carcinoma of the thyroid.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9534706     DOI: 10.1259/bjr.71.841.9534706

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  3 in total

1.  Surgical treatment of Hurthle cell tumors of the thyroid.

Authors:  Tzu-Chieh Chao; Jen-Der Lin; Miin-Fu Chen
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

Review 2.  Hurthle cell carcinoma of the thyroid.

Authors:  Mark Anthony S Sandoval; Elizabeth Paz-Pacheco
Journal:  BMJ Case Rep       Date:  2011-02-09

Review 3.  Recent Development of Nuclear Molecular Imaging in Thyroid Cancer.

Authors:  Huiting Liu; Xiaoqin Wang; Ran Yang; Wenbing Zeng; Dong Peng; Jason Li; Hu Wang
Journal:  Biomed Res Int       Date:  2018-05-21       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.